Barclays’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-38,299
| Closed | -$5.22M | – | 5278 |
|
|
2020
Q3 | $5.22M | Sell |
38,299
-8,100
| -17% | -$861K | ﹤0.01% | 1366 |
|
|
2020
Q2 | $4.48M | Buy |
46,399
+10,808
| +30% | +$902K | ﹤0.01% | 1464 |
|
|
2020
Q1 | $1.67M | Sell |
35,591
-69,429
| -66% | -$4.45M | ﹤0.01% | 2454 |
|
|
2019
Q4 | $7.65M | Buy |
105,020
+75,750
| +259% | +$4.59M | ﹤0.01% | 1595 |
|
|
2019
Q3 | $1.53M | Sell |
29,270
-538
| -2% | -$28.6K | ﹤0.01% | 3202 |
|
|
2019
Q2 | $1.49M | Buy |
29,808
+6,786
| +29% | +$330K | ﹤0.01% | 3252 |
|
|
2019
Q1 | $1.2M | Buy |
23,022
+16,378
| +247% | +$755K | ﹤0.01% | 3207 |
|
|
2018
Q4 | $325K | Sell |
6,644
-9,319
| -58% | -$513K | ﹤0.01% | 4212 |
|
|
2018
Q3 | $1.04M | Buy |
15,963
+11,841
| +287% | +$696K | ﹤0.01% | 3580 |
|
|
2018
Q2 | $205K | Sell |
4,122
-10,385
| -72% | -$503K | ﹤0.01% | 4703 |
|
|
2018
Q1 | $709K | Buy |
14,507
+4,172
| +40% | +$217K | ﹤0.01% | 3597 |
|
|
2017
Q4 | $435K | Sell |
10,335
-3,892
| -27% | -$150K | ﹤0.01% | 3998 |
|
|
2017
Q3 | $610K | Buy |
14,227
+7,191
| +102% | +$229K | ﹤0.01% | 3426 |
|
|
2017
Q2 | $92K | Sell |
7,036
-692
| -9% | -$9.12K | ﹤0.01% | 4970 |
|
|
2017
Q1 | $102K | Sell |
7,728
-375
| -5% | -$4.8K | ﹤0.01% | 4868 |
|
|
2016
Q4 | $105K | Buy |
8,103
+63
| +0.8% | +$970 | ﹤0.01% | 4712 |
|
|
2016
Q3 | $132K | Buy |
8,040
+342
| +4% | +$6.17K | ﹤0.01% | 4308 |
|
|
2016
Q2 | $95K | Hold |
7,698
| – | – | ﹤0.01% | 4440 |
|
|
2016
Q1 | $77K | Buy |
7,698
+7,563
| +5,602% | +$68.8K | ﹤0.01% | 4530 |
|
|
2015
Q4 | $2K | Buy |
+135
| New | +$1.65K | ﹤0.01% | 5775 |
|
Barclays's MYOK Position: Q4 2020 in Review
Barclays sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 38,299 shares — an estimated $5.22M sold.
Barclays first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $7.65M in Q4 2019. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Barclays reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Barclays sold 38,299 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $5.22M.
- Barclays first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Barclays's MyoKardia, Inc. Common Stock position peaked at $7.65M in Q4 2019.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Barclays's 13F filing for Q4 2020, filed 11 Feb 2021.